NasdaqCM - Delayed Quote • USD
Brainstorm Cell Therapeutics Inc. (BCLI)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:58 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
21,550.0000
24,822.0000
24,539.0000
31,684.0000
Operating Income
-21,550.0000
-24,822.0000
-24,539.0000
-31,684.0000
Net Non Operating Interest Income Expense
-12.0000
545.0000
82.0000
-127.0000
Pretax Income
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Net Income Common Stockholders
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Diluted NI Available to Com Stockholders
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Basic EPS
-0.42
-0.66
-0.68
-1.07
Diluted EPS
-0.42
-0.66
-0.68
-1.07
Basic Average Shares
39,346.4080
36,509.0600
36,181.7530
29,848.2170
Diluted Average Shares
39,346.4080
36,509.0600
36,181.7530
29,848.2170
Total Operating Income as Reported
-21,550.0000
-24,822.0000
-24,539.0000
-31,684.0000
Total Expenses
21,550.0000
24,822.0000
24,539.0000
31,684.0000
Net Income from Continuing & Discontinued Operation
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Normalized Income
-21,562.0000
-24,277.0000
-24,457.0000
-31,811.0000
Interest Income
--
545.0000
82.0000
--
Net Interest Income
-12.0000
545.0000
82.0000
-127.0000
EBIT
-21,550.0000
-24,822.0000
-24,539.0000
-31,684.0000
EBITDA
-21,281.0000
-24,537.0000
-24,279.0000
-31,465.0000
Reconciled Depreciation
269.0000
285.0000
260.0000
219.0000
Net Income from Continuing Operation Net Minority Interest
-16,632.0000
-24,277.0000
-24,457.0000
-31,811.0000
Total Unusual Items Excluding Goodwill
4,930.0000
--
--
--
Total Unusual Items
4,930.0000
--
--
--
Normalized EBITDA
-26,211.0000
-24,537.0000
-24,279.0000
-31,465.0000
12/31/2020 - 10/7/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AMLX Amylyx Pharmaceuticals, Inc.
1.7600
-1.12%
BLRX BioLineRx Ltd.
0.6116
+6.31%
KZIA Kazia Therapeutics Limited
0.3700
+1.43%
ALZN Alzamend Neuro, Inc.
0.7195
-0.90%
VINC Vincerx Pharma, Inc.
0.7300
-18.59%
PBLA Panbela Therapeutics, Inc.
0.4100
-6.82%
SNGX Soligenix, Inc.
0.4150
-2.81%
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%
PXMD PaxMedica, Inc.
0.7398
+5.06%
MNPR Monopar Therapeutics Inc.
0.6582
+4.81%